Investors & Shareholders
Market and financial information
Listed since 2010 at BME Growth
Since 2010, Altia has been listed on BME Growth, the market for BME SMEs. Currently, it is part of the IBEX MAB® All Share.
* Increase in NFD (Net Financial Debt) due to the financing of the acquisitions of Wairbut and Bilbomática. Leverage: 0.6x NFD/EBITDA.
** The dividend proposed by the Board of Directors is EUR 0.040 per share after the split (EUR 0.40 in terms of historic yields equivalents).
Consolidated figures since 2019 under IFRS regulations.
News for the investor
paula.lodeiros.web | 27 April
“In a complex environment, we have grown and new people have joined the project, new concerns and needs have arisen, as well as new approaches, perspectives
ines.fernandez | 31 March
Resultados de 2022 Net profit€10,2 M16,6% more than in 2021 Turnover €167,2 M32,8% more than in 2021 EBITDA€16,6 M18,4% more
melina.caviale | 06 March
“Altia’s track record and robustness has led the Board of Directors to believe it necessary to enhance share liquidity, the share price currently being